Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tracey G Simon

Showing results (1-10 of 128) with videos related to

Pageof 13
Sort By:
The Lancet. Gastroenterology & Hepatology|October 15, 2019
When less is more: dosing simvastatin in decompensated cirrhosisTracey G Simon
World Journal of Gastroenterology|July 29, 2015
Lipid dysregulation in hepatitis C virus, and impact of statin therapy upon clinical outcomesTracey G Simon, Adeel A Butt
The New England Journal of Medicine|June 20, 2020
Association between Aspirin and Hepatocellular Carcinoma. ReplyTracey G Simon, Jonas F Ludvigsson
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 29, 2019
ReplyTracey G Simon, Kathleen E Corey
Hepatology (Baltimore, Md.)|June 11, 2015
The new hepatitis C virus bottleneck: Can delaying therapy be justified?Tracey G Simon, Raymond T Chung
JAMA Oncology|May 3, 2019
Reduced Hepatocellular Carcinoma Risk vs Bleeding Risk Associated With Aspirin-In ReplyTracey G Simon, Andrew T Chan
Alimentary Pharmacology & Therapeutics|January 29, 2022
Editorial: time to eat? Skipping breakfast in metabolic-associated fatty liver diseaseRobert M Wilechansky, Tracey G Simon
JAMA|July 18, 2024
Low-Dose Aspirin and Hepatic Fat Quantity in Patients With MASLD-ReplyTracey G Simon, Andrew T Chan
Clinics in Liver Disease|October 5, 2020
Lifestyle and Environmental Approaches for the Primary Prevention of Hepatocellular CarcinomaTracey G Simon, Andrew T Chan
Hepatology (Baltimore, Md.)|August 29, 2015
ReplyTracey G Simon, Raymond T Chung
Pageof 13

Showing results (1-10 of 128) with videos related to

Sort By:
Pageof 13
The Lancet. Gastroenterology & Hepatology|October 15, 2019
When less is more: dosing simvastatin in decompensated cirrhosisTracey G Simon
World Journal of Gastroenterology|July 29, 2015
Lipid dysregulation in hepatitis C virus, and impact of statin therapy upon clinical outcomesTracey G Simon, Adeel A Butt
The New England Journal of Medicine|June 20, 2020
Association between Aspirin and Hepatocellular Carcinoma. ReplyTracey G Simon, Jonas F Ludvigsson
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 29, 2019
ReplyTracey G Simon, Kathleen E Corey
Hepatology (Baltimore, Md.)|June 11, 2015
The new hepatitis C virus bottleneck: Can delaying therapy be justified?Tracey G Simon, Raymond T Chung
JAMA Oncology|May 3, 2019
Reduced Hepatocellular Carcinoma Risk vs Bleeding Risk Associated With Aspirin-In ReplyTracey G Simon, Andrew T Chan
Alimentary Pharmacology & Therapeutics|January 29, 2022
Editorial: time to eat? Skipping breakfast in metabolic-associated fatty liver diseaseRobert M Wilechansky, Tracey G Simon
JAMA|July 18, 2024
Low-Dose Aspirin and Hepatic Fat Quantity in Patients With MASLD-ReplyTracey G Simon, Andrew T Chan
Clinics in Liver Disease|October 5, 2020
Lifestyle and Environmental Approaches for the Primary Prevention of Hepatocellular CarcinomaTracey G Simon, Andrew T Chan
Hepatology (Baltimore, Md.)|August 29, 2015
ReplyTracey G Simon, Raymond T Chung
Pageof 13